Report - Les 8 et 9 novembre 2018 Palais Brongniart · 2018. 2. 23. · Amgen, JnJ, Kyowa Hakko Kirin, Mundipharma, Novartis, Pierre Fabre, Pfizer Roche, Sandoz, Taiho, Teva n Executive Committee

Please pass captcha verification before submit form